Erlocip 100 mg Tab(Erlotinib)

Erlocip 100 mg Tab(Erlotinib)

A product by Cipla called Erlocip is tyrosine kinase inhibitor, it kills the affected cancer cells during the process by preventing the growth of them.  This is the reason this tablet is not prescribed for hypersensitive patient or platinum based chemotherapy patient

Erlocip is administered to the patients who are suffering from lung cancer or metastatic lung cancer which is now at advanced stage. It is also being given to the patients having pancreatic cancer with the combination of other drugs. As this medicine is considered as a tyrosine kinase inhibitor which is usually prescribed for lung cancer.

Substitute Available

1. Erlotib 100 mg Tab (by Intas Pharmaceuticals Ltd)

2. Erlonat 100 mg Tab (by Natco Pharma Ltd)